Stay updated on ALADDIN Clinical Trial: dAroLutamide in Prostate Cancer
Sign up to get notified when there's something new on the ALADDIN Clinical Trial: dAroLutamide in Prostate Cancer page.

Latest updates to the ALADDIN Clinical Trial: dAroLutamide in Prostate Cancer page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedNew actions 'Check who can join' and 'Find Contact Information' have been added to the history page, expanding access to enrollment criteria and study contact details. A new revision marker v3.6.0 appears, replacing the previous v3.5.5 entry.SummaryDifference0.6%

- Check19 days agoChange DetectedThe study record history shows a new revision entry (v3.5.5) that replaces the previous v3.5.4. This represents a minor update to the page's history metadata rather than changes to the trial data or study details.SummaryDifference0.1%

- Check41 days agoChange DetectedThe page now displays Revision: v3.5.4, replacing the previous revision. This reflects a new release version for the study history page.SummaryDifference0.1%

- Check62 days agoChange DetectedA UI/version update is reflected on the page (revision moved from v3.5.2 to v3.5.3), without any corresponding changes to the clinical trial’s recorded information.SummaryDifference0.1%

- Check69 days agoChange DetectedRevision: v3.5.2 was added to the history, replacing Revision: v3.5.0.SummaryDifference0.1%

- Check98 days agoChange DetectedAdded a new Revision: v3.5.0 to the record history and removed Revision: v3.4.3.SummaryDifference0.1%

Stay in the know with updates to ALADDIN Clinical Trial: dAroLutamide in Prostate Cancer
Enter your email address, and we'll notify you when there's something new on the ALADDIN Clinical Trial: dAroLutamide in Prostate Cancer page.